Centers for Medicare & Medicaid Services #270037

Evaluation Services for GLOBE & GUARD Drug Pricing Models (CMS)

This opportunity is for an evaluation contract supporting the Centers for Medicare & Medicaid Services (CMS) under the Department of Health and Human Services. - Government Buyer: - Centers for Medicare & Medicaid Services (CMS), Department of Health and Human Services - Scope of Work: - Evaluation of the GLOBE (Global Benchmark for Efficient Drug Pricing) and GUARD (Guarding U.S. Medicare Against Rising Drug Costs) models - GLOBE model: Assesses rebates for certain Medicare Part B drugs if U.S. prices exceed those in comparable countries - GUARD model: Applies similar rebate assessments for Medicare Part D drugs - Products/Services Requested: - Evaluation services for both GLOBE and GUARD models - No specific products, part numbers, or OEMs are identified - Notable Requirements: - Contract will be issued as a Cost Plus Fixed Fee IDIQ/GWAC Order under the CMS RMADA 2 IDIQ - NAICS code: 541720 (Research and Development in the Social Sciences and Humanities) - Product Service Code: AN42 - Competitive procurement with no set aside - Estimated contract value between $10M and $20M - Period of performance is greater than five years

Description

The solicitation is for the GLOBE & GUARD Model - Evaluation Contract. The GLOBE Model is a proposed mandatory model to assess rebates for certain drugs payable under Medicare Part B if prices exceed those in economically comparable countries. The GUARD Model is a proposed mandatory model to assess rebates for certain drugs payable under Medicare Part D under similar conditions. The contract is planned to be awarded on 09/01/2026 with a period of performance starting 11/02/2026 and lasting over 5 years. The contract type is Cost Plus Fixed Fee under an IDIQ/GWAC Order - Competitive acquisition method with no set aside used.

View original listing